Healthtech Startups
16,918 companies tagged Healthtech, with their investors and founders.
ByHeart is an infant formula company that manufactures science-driven baby formula with its own manufacturing process and supply chain. The page addresses a Clostridium botulinum contamination outbreak and outlines new testing protocols and safety controls for its products, sold to families in the US.
2 investors
Hyperion Biosystems builds diagnostic devices that use computer vision and physics-based algorithms to improve the sensitivity and specificity of point-of-care and at-home tests. Its products include the HALO platform and Helios, a rapid molecular diagnostic platform combining padlock probe chemistry, isothermal amplification, and optical readout for multiplexed, single-copy detection.
2 investors
Caddie Health provides AI-powered medical billing software that recommends billing codes for visits, screens and verifies claims for errors before submission, and offers real-time dashboards to track billing performance. The product targets healthcare providers looking to reduce claim rejections and improve billing revenue.
2 investors
Cadence provides over-the-counter contraceptive products including morning-after pills, pregnancy tests, and UTI relief kits distributed through convenience stores. The company focuses on improving access to affordable reproductive health products without prescription or insurance requirements.
2 investors
Caedo Oncology develops therapeutic antibodies for cancer treatment, leveraging deep immunology and antibody engineering expertise.
2 investors
CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases. Its drug candidates target conditions such as acute pancreatitis, acute kidney injury, and pulmonary arterial hypertension.
2 investors
CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry. The FDA-approved and UKCA-marked system is aimed at dental clinicians managing caries and erosion.
2 investors
Caldera is a clinical-stage biotechnology company developing CLD-423, a bispecific antibody targeting the IL-23p19 and TL1A pathways for inflammatory bowel disease and other immunologic and inflammatory diseases. Its lead candidate is in a Phase 1 healthy volunteer trial.
2 investors
Call9 provides emergency and palliative care to patients in skilled nursing facilities by combining onsite clinical care specialists with remote emergency medicine physicians who evaluate and treat patients via a proprietary platform, reducing response times from an average of 64 minutes to immediate care.
2 investors
Calliditas is a biopharmaceutical company developing and commercializing treatments for renal and other conditions, including TARPEYO/Nefecon/Kinpeygo (budesonide) for primary IgA nephropathy and NOX inhibitor candidates such as setanaxib for fibrotic diseases and cancer. It works with commercial partners including Everest Medicines and STADA to bring its therapies to markets such as the US, UK, EU, and China.
2 investors
Cambridge Nutraceuticals develops and sells health supplements grounded in clinical research and scientific evidence, serving consumers seeking science-backed nutritional products. The company manufactures supplements with proven active ingredients and partners with leading academic research institutions.
2 investors
cAMPfield is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for immune-mediated inflammatory diseases, primarily inflammatory bowel disease (ulcerative colitis and Crohn's disease). The company is advancing the drug into global Phase 2 clinical development.
2 investors
Canomiks is a life sciences company focused on developing treatments and research in diabetes, cardiovascular disease, and related areas, drawing on expertise in pharmacology, genomics, and bioinformatics.
2 investors
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.
2 investors
Canurta Therapeutics develops multi-target botanical drugs using its AI-backed PolyKye platform to identify bioactive compounds and guide compound selection, disease targeting, and formulation. Its therapies target inflammation and neurological diseases, with a lead candidate (CNR-401) aimed at Amyotrophic Lateral Sclerosis (ALS).
2 investors
CapExpert is an AI-powered platform for healthcare asset management, letting providers inventory, maintain, source, and redeploy capital medical equipment across its lifecycle. It serves healthcare providers and vendors, positioning itself as an operating system for medical equipment.
2 investors
Capstan Medical develops surgical robotics combined with catheter-based technology and next-generation implants to repair and replace heart valves. Its minimally invasive approach targets structural heart disease, including mitral and tricuspid valve conditions, as an alternative to open heart surgery.
2 investors
Philips Capsule provides healthcare informatics solutions for hospitals and health systems, including medical device integration, system integration, cloud data storage and analytics, clinical surveillance, patient data management, and virtual care. Now part of the Philips Acute Care Informatics portfolio, its vendor-neutral platform connects live data from over 1,200 medical devices to more than 100 clinical systems.
2 investors
CAPS operates a clinic chain management business, offers corporate health management support services, runs fitness facilities, and provides health education programs in Japan.
2 investors
CaptureProof develops a telemedicine platform that enables the secure capture, comparison, and asynchronous sharing of medical photos and videos between patients and healthcare providers. The platform serves physicians and patients across various medical specialties including cardiology, orthopedics, and neurology.
2 investors
2 investors
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing. The platform serves pharmaceutical researchers and drug development teams evaluating therapeutic efficacy before in vivo studies.
2 investors
Cardamom is a healthcare consulting and technology firm that helps healthcare organizations improve patient access, engagement, and retention through Epic-first configuration, CRM integration, and AI-enhanced methods. It serves health systems and providers by connecting people, process, and technology to reduce friction in patient interactions.
2 investors
Cardiac Booster develops cardiac support technology for use in treating heart conditions. The company operates in the medical device sector.
2 investors